Here, we found that FBL is highly expressed in ESCC tissues, negatively associated with patient prognosis, and vital for ESCC cell growth via stimulation of PI3K/AKT signaling and promotion of cell cycle progression, indicating that FBL is a potential therapeutic target against ESCC. Here, FBL is linked to esophageal squamous cell carcinoma.